Orbis Allan Gray LTD Genmab A/S Transaction History
Orbis Allan Gray LTD
- $13.9 Billion
- Q1 2025
A detailed history of Orbis Allan Gray LTD transactions in Genmab A/S stock. As of the latest transaction made, Orbis Allan Gray LTD holds 5,710,741 shares of GMAB stock, worth $126 Million. This represents 0.8% of its overall portfolio holdings.
Number of Shares
5,710,741
Previous 2,815,562
102.83%
Holding current value
$126 Million
Previous $58.8 Million
90.29%
% of portfolio
0.8%
Previous 0.4%
Shares
3 transactions
Others Institutions Holding GMAB
# of Institutions
248Shares Held
66.2MCall Options Held
729KPut Options Held
398K-
Alliancebernstein L.P. New York, NY14.7MShares$324 Million0.11% of portfolio
-
Black Rock Inc. New York, NY5.08MShares$112 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il4.43MShares$97.5 Million0.02% of portfolio
-
Harding Loevner LP Bridgewater, NJ2.88MShares$63.5 Million0.45% of portfolio
-
Morgan Stanley New York, NY2.84MShares$62.5 Million0.0% of portfolio
About GENMAB A/S
- Ticker GMAB
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 658,292,992
- Market Cap $14.5B
- Description
- Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...